Moore Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Moore Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-125,000	Closed	-$229K	–	352
2018 Q1	$229K	Sell	125,000 -100,000	-44%	-$211K	﹤0.01%	230
2017 Q4	$502K	Hold	225,000	–	–	0.01%	231
2017 Q3	$653K	Hold	225,000	–	–	0.01%	200
2017 Q2	$1M	Hold	225,000	–	–	0.03%	156
2017 Q1	$1.05M	Buy	+225,000	New	+$1.3M	0.03%	163
2016 Q1	–	Sell	-665,000	Closed	-$3.77M	–	370
2015 Q4	$3.77M	Buy	665,000 +440,000	+196%	+$2.68M	0.12%	153
2015 Q3	$1.19M	Sell	225,000 -100,000	-31%	-$774K	0.06%	231
2015 Q2	$2.7M	Buy	+325,000	New	+$1.58M	0.06%	278

Other funds holding SGYP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Moore Capital Management's SGYP Position: Q2 2018 in Review

Moore Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2018, closing a stake of 125,000 shares — an estimated $229K sold.

Moore Capital Management first reported a position in SGYP in Q2 2015 and held it in 8 quarters. The position peaked at $3.77M in Q4 2015. 137 funds tracked by Wall St. Rank hold SGYP as of Q2 2018.

Moore Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2018 after selling out during the quarter.
Moore Capital Management sold 125,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2018, an estimated $229K.
Moore Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 8 quarters.
Moore Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $3.77M in Q4 2015.
137 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2018.

Based on Moore Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.